Revvity Discovery Limited
Private Limited Company · Cambridge
ActiveUnited KingdomIncorporated 2005Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No processed account filings
No processed accounts are available in our records.
Registered details
05363294- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2005-02-14
- Jurisdiction
- —
- Registered office
- 8100, CAMBRIDGE RESEARCH PARK, CAMBRIDGE, CB25 9TL, UNITED KINGDOM
Classification
1 SIC codes23012
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
7 matched grantsNext generation high-yield producer platform for cell and gene therapy viral vectors and other complex biologics.LiveInnovate UK · Collaborative R&D · 2024-05-01 – 2027-03-31 · with 3 other participants£125,993awarded
Next generation high-yield producer platform for cell and gene therapy viral vectors and other complex biologics.Live
Innovate UK · Collaborative R&D · 2024-05-01 – 2027-03-31 · with 3 other participants
£125,993
awarded
Horizon Discovery Limited£125,993
National Research Council Canada£0
VVector Bio Inclead£0
Reference standards to enable standardization and wide-spread implementation of non-invasive prenatal testing for chromosome aneuploidiesLeadInnovate UK · Collaborative R&D · 2018-12-01 – 2021-08-31 · with 2 other participants£180,016awarded
Reference standards to enable standardization and wide-spread implementation of non-invasive prenatal testing for chromosome aneuploidiesLead
Innovate UK · Collaborative R&D · 2018-12-01 – 2021-08-31 · with 2 other participants
£180,016
awarded
Horizon Discovery Limitedlead£180,016
St George’s University Hospital£74,928
Manchester University NHS Foundation Trust£50,305
Disrupting the global market for high value, gene-edited cell products and services with microfluidic technologyInnovate UK · Collaborative R&D · 2017-07-01 – 2020-10-31 · with 3 other participants£7,734awarded
Disrupting the global market for high value, gene-edited cell products and services with microfluidic technology
Innovate UK · Collaborative R&D · 2017-07-01 – 2020-10-31 · with 3 other participants
£7,734
awarded
University of Edinburgh£299,814
Horizon Discovery Limited£7,734
Development of an automated manufacturing pipeline for genome-edited mammalian cellsLeadInnovate UK · Collaborative R&D · 2017-04-01 – 2019-04-30 · with 1 other participant£277,012awarded
Development of an automated manufacturing pipeline for genome-edited mammalian cellsLead
Innovate UK · Collaborative R&D · 2017-04-01 – 2019-04-30 · with 1 other participant
£277,012
awarded
Horizon Discovery Limitedlead£277,012
Combinatorial genome editing to create enhanced biomanufacturing platformsLeadInnovate UK · Collaborative R&D · 2015-05-01 – 2018-11-30 · with 2 other participants£747,562awarded
Combinatorial genome editing to create enhanced biomanufacturing platformsLead
Innovate UK · Collaborative R&D · 2015-05-01 – 2018-11-30 · with 2 other participants
£747,562
awarded
Horizon Discovery Limitedlead£747,562
Enabling stratified medicine through cell and tissue reference standards for minimally invasive cancer testingLeadInnovate UK · Collaborative R&D · 2014-07-01 – 2016-03-31 · with 1 other participant£227,756awarded
Enabling stratified medicine through cell and tissue reference standards for minimally invasive cancer testingLead
Innovate UK · Collaborative R&D · 2014-07-01 – 2016-03-31 · with 1 other participant
£227,756
awarded
Horizon Discovery Limitedlead£227,756
InsightLead
Innovate UK · EU-Funded · 2012-01-01 – 2013-02-28
£262,736
awarded